Goodwin
Dan Karelitz
- Deals
- 9
- Latest
- Aug 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 9 deals
Often works with
- Arman Oruc 4 deals together
- Julie Tibbets 3 deals together
- Heath Ingram 3 deals together
- Kevin Walsh 3 deals together
- Dasol Lee 3 deals together
- Sarah Solomon 2 deals together
- Noelle Dubiansky 2 deals together
- Timothy Holahan 2 deals together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Aug 2026 | Amylyx Pharmaceuticals | – | – | Follow-on offering | Legal adviser to the issuer | Announced | 575.2 | Biotech+1 | Amylyx Pharmaceuticals equity raising |
| Jun 2026 | Vendr | – | Vertice Technology | Acquisition | Legal adviser to Vendr (target) | Announced | – | SaaS+1 | Vertice Technology acquisition of Vendr |
| May 2026 | Anagram Therapeutics | – | – | Stake | Legal adviser to Anagram Therapeutics (target) | Announced | – | Biotech+2 | Stake in Anagram Therapeutics |
| May 2026 | Perfuse Therapeutics | – | Bayer | Acquisition | Legal adviser to Perfuse Therapeutics (target) | Announced | 300.0 | Biotech+2 | Bayer acquisition of Perfuse Therapeutics |
| Apr 2026 | Shionogi-Apnimed Sleep Science | Apnimed | Shionogi & Co. | Acquisition | Legal adviser to Apnimed (seller) | Announced | 100.0 | Pharma+1 | Shionogi & Co. acquisition of Shionogi-Apnimed Sleep Science |
| Apr 2026 | CathWorks | – | Medtronic | Acquisition | Legal adviser to CathWorks (target) | Announced | 585.0 | Medtech+1 | Medtronic acquisition of CathWorks |
| Apr 2026 | Kelonia Therapeutics | – | Eli Lilly and Company | Acquisition | Legal adviser to Kelonia Therapeutics (target) | Announced | 7,000.0 | Biotech+2 | Eli Lilly and Company acquisition of Kelonia Therapeutics |
| Apr 2026 | Worldwide rights to Kenalog | Bristol-Myers Squibb | Subsidiary of Piramal Pharma | Asset sale | Legal adviser to subsidiary of Piramal Pharma (acquirer) | Announced | 35.0 | Pharma | Subsidiary of Piramal Pharma acquisition of Worldwide rights to Kenalog |
| Mar 2026 | Pikavation | Synnovation | Novartis | Acquisition | Legal adviser to Synnovation Therapeutics (seller) | Announced | 2,000.0 | Biotech+2 | Novartis acquisition of Pikavation |
Deals where Dan Karelitz is named on the firm's deal team, by the firm or the press.